Tags

Type your tag names separated by a space and hit enter

Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
Scand J Clin Lab Invest. 2007; 67(2):215-25.SJ

Abstract

OBJECTIVE

Resistin has been linked to obesity, type 2 diabetes, inflammation and atherosclerosis but the results of animal and human studies have been at variance. The purpose of this study was to investigate the potential roles of resistin in patients with type 2 diabetes and to evaluate the correlation between resistin and markers of obesity, inflammation, insulin resistance, metabolic parameters, diabetes control and complications.

MATERIAL AND METHODS

Fasting resistin, leptin, insulin, glucose, HbA1c, full lipid profile, C-reactive protein (CRP) (high sensitivity assay) and complete blood count were determined in 135 patients with type 2 diabetes. Univariate regression and multivariate logistic regression analyses were used to relate resistin with indices of obesity, inflammation, insulin resistance (homeostasis model, HOMA), insulin sensitivity, diabetic control, coronary heart disease (CHD) and degree of microalbuminuria.

RESULTS

Resistin showed significant (p<0.05) correlations with body mass index (BMI) "(Spearman r=0.67), waist circumference (r=0.54), fasting insulin (0.51), insulin sensitivity (r=-0.29), HOMA (r=0.30), leptin (r=0.39), CRP (r=0.29), white cell count (r=0.25) and lipid parameters but showed no significant correlation with glucose and HbA1c. Partial correlation analysis, with correction for BMI, abolished the correlation of resistin with insulin sensitivity and HOMA but not with the white cell count. When confounding factors were fixed using multiple logistic regression, resistin was not independently associated with CHD (odds ratio=1.05, p=0.08) and degree of microalbuminuria (odds ratio=1.06, p=0.24).

CONCLUSIONS

Resistin showed significant BMI-dependent associations with insulin resistance and factors linked with obesity and inflammation in patients with type 2 diabetes. Resistin may represent a link between obesity and insulin resistance via pro-inflammatory pathways.

Authors+Show Affiliations

Department of Pathology, Faculty of Medicine, Kuwait University, Kuwait. segunade@yahoo.comNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

17366001

Citation

Mojiminiyi, O A., and N A. Abdella. "Associations of Resistin With Inflammation and Insulin Resistance in Patients With Type 2 Diabetes Mellitus." Scandinavian Journal of Clinical and Laboratory Investigation, vol. 67, no. 2, 2007, pp. 215-25.
Mojiminiyi OA, Abdella NA. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scand J Clin Lab Invest. 2007;67(2):215-25.
Mojiminiyi, O. A., & Abdella, N. A. (2007). Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. Scandinavian Journal of Clinical and Laboratory Investigation, 67(2), 215-25.
Mojiminiyi OA, Abdella NA. Associations of Resistin With Inflammation and Insulin Resistance in Patients With Type 2 Diabetes Mellitus. Scand J Clin Lab Invest. 2007;67(2):215-25. PubMed PMID: 17366001.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus. AU - Mojiminiyi,O A, AU - Abdella,N A, PY - 2007/3/17/pubmed PY - 2007/5/9/medline PY - 2007/3/17/entrez SP - 215 EP - 25 JF - Scandinavian journal of clinical and laboratory investigation JO - Scand. J. Clin. Lab. Invest. VL - 67 IS - 2 N2 - OBJECTIVE: Resistin has been linked to obesity, type 2 diabetes, inflammation and atherosclerosis but the results of animal and human studies have been at variance. The purpose of this study was to investigate the potential roles of resistin in patients with type 2 diabetes and to evaluate the correlation between resistin and markers of obesity, inflammation, insulin resistance, metabolic parameters, diabetes control and complications. MATERIAL AND METHODS: Fasting resistin, leptin, insulin, glucose, HbA1c, full lipid profile, C-reactive protein (CRP) (high sensitivity assay) and complete blood count were determined in 135 patients with type 2 diabetes. Univariate regression and multivariate logistic regression analyses were used to relate resistin with indices of obesity, inflammation, insulin resistance (homeostasis model, HOMA), insulin sensitivity, diabetic control, coronary heart disease (CHD) and degree of microalbuminuria. RESULTS: Resistin showed significant (p<0.05) correlations with body mass index (BMI) "(Spearman r=0.67), waist circumference (r=0.54), fasting insulin (0.51), insulin sensitivity (r=-0.29), HOMA (r=0.30), leptin (r=0.39), CRP (r=0.29), white cell count (r=0.25) and lipid parameters but showed no significant correlation with glucose and HbA1c. Partial correlation analysis, with correction for BMI, abolished the correlation of resistin with insulin sensitivity and HOMA but not with the white cell count. When confounding factors were fixed using multiple logistic regression, resistin was not independently associated with CHD (odds ratio=1.05, p=0.08) and degree of microalbuminuria (odds ratio=1.06, p=0.24). CONCLUSIONS: Resistin showed significant BMI-dependent associations with insulin resistance and factors linked with obesity and inflammation in patients with type 2 diabetes. Resistin may represent a link between obesity and insulin resistance via pro-inflammatory pathways. SN - 0036-5513 UR - https://www.unboundmedicine.com/medline/citation/17366001/Associations_of_resistin_with_inflammation_and_insulin_resistance_in_patients_with_type_2_diabetes_mellitus_ L2 - http://www.tandfonline.com/doi/full/10.1080/00365510601032532 DB - PRIME DP - Unbound Medicine ER -